dehydroepiandrosterone has been researched along with Diabetic Retinopathy in 5 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This cross-sectional study assessed the association of serum dehydroepiandrosterone levels with the risk of diabetic retinopathy in patients with type 2 diabetes mellitus in China." | 8.31 | Low serum dehydroepiandrosterone levels are associated with diabetic retinopathy in patients with type 2 diabetes mellitus. ( Feng, W; Huang, Y; Liu, M; Qiao, J; Xu, N; Zhang, X, 2023) |
| "This cross-sectional study assessed the association of serum dehydroepiandrosterone levels with the risk of diabetic retinopathy in patients with type 2 diabetes mellitus in China." | 4.31 | Low serum dehydroepiandrosterone levels are associated with diabetic retinopathy in patients with type 2 diabetes mellitus. ( Feng, W; Huang, Y; Liu, M; Qiao, J; Xu, N; Zhang, X, 2023) |
| "Early diabetic retinopathy is characterized by a loss of pericytes and vascular endothelial cells, a breakdown of the blood-retinal barrier, vascular dysfunction and vascular-neuroinflammation." | 1.43 | MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy. ( Wang, Y; Yan, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 1 |
| Huang, Y | 1 |
| Xu, N | 1 |
| Feng, W | 1 |
| Qiao, J | 1 |
| Liu, M | 1 |
| Ibán-Arias, R | 1 |
| Lisa, S | 1 |
| Poulaki, S | 1 |
| Mastrodimou, N | 1 |
| Charalampopoulos, I | 1 |
| Gravanis, A | 1 |
| Thermos, K | 1 |
| Wang, Y | 1 |
| Yan, H | 1 |
| BRETAN, M | 1 |
| SZABO, Z | 1 |
| JAKAB, L | 1 |
| BALAZSI, I | 1 |
| Haffner, SM | 1 |
| Klein, R | 1 |
| Dunn, JF | 1 |
| Moss, SE | 1 |
| Klein, BE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)[NCT00005146] | 0 participants | Observational | 1979-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for dehydroepiandrosterone and Diabetic Retinopathy
| Article | Year |
|---|---|
Low serum dehydroepiandrosterone levels are associated with diabetic retinopathy in patients with type 2 diabetes mellitus.
Topics: Cross-Sectional Studies; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Hu | 2023 |
Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina.
Topics: Administration, Topical; Animals; Blotting, Western; Dehydroepiandrosterone; Diabetes Mellitus, Expe | 2019 |
MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy.
Topics: Angiogenesis Inducing Agents; Angiogenic Proteins; Animals; Apoptosis; Ascorbic Acid; Blood Glucose; | 2016 |
[EFFECT OF TREATMENT WITH NOR-ANDROSTENOLONE AND DECANOATE ON DIABETIC RETINOPATHY].
Topics: Adolescent; Carbohydrate Metabolism; Decanoates; Dehydroepiandrosterone; Diabetes Mellitus, Type 1; | 1964 |
Increased testosterone in type I diabetic subjects with severe retinopathy.
Topics: Adolescent; Adult; Body Constitution; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabet | 1990 |